Yazan Abou-Ismail, MD

Journal Article

1. Abou-Ismail MY, Khalife R (2025). Navigating the challenges of neuraxial anesthesia in patients with platelet and coagulation disorders: commentary on the ISTH SSC Delphi Consensus recommendations. J Thromb Haemost, 23(6), 1771-1773. (Read full article)
2. Mahmoud AA, Mostafa M, Abdelhay A, Abou-Ismail MY, Chaturvedi S (2024). Characterization of bleeding in thrombotic thrombocytopenic purpura in the precaplacizumab era: a retrospective nationwide analysis. Res Pract Thromb Haemost, 9(1), 102654. (Read full article)
3. Lim MY, Abou-Ismail MY (2024). Double-heterozygous FVL/PTGM: double the trouble. Blood, 143(23), 2347-2349. (Read full article)
4. Abou-Ismail MY, Zhang C, Presson AP, Chaturvedi S, Antun AG, Farland AM, Woods R, Metjian A, Park YA, de Ridder G, Gibson B, Kasthuri RS, Liles DK, Akwaa F, Clover T, Kreuziger LB, Sridharan M, Go RS, McCrae KR, Upreti HV, Gangaraju R, Kocher NK, Zheng XL, Raval JS, Masias C, Cataland SR, Johnson AD, Davis E, Evans MD, Mazepa M, Lim MY (2024). A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpura. Res Pract Thromb Haemost, 8(3), 102388. (Read full article)
5. Abou-Ismail MY, van der Wal DE, Cheong MA, Masten A, Blount L, Brown MC (2024). Can scientific journals benefit from a social media presence? An analysis of online traffic data and author perspectives. Res Pract Thromb Haemost, 8(3), 102387. (Read full article)
6. Abou-Ismail MY, Zhang C, Presson AP, Chaturvedi S, Antun AG, Farland AM, Woods R, Metjian A, Park YA, de Ridder G, Gibson B, Kasthuri RS, Liles DK, Akwaa F, Clover T, Baumann Kreuziger L, Sridharan M, Go RS, McCrae KR, Upreti HV, Gangaraju R, Kocher NK, Zheng XL, Raval JS, Masias C, Cataland SR, Johnson AD, Davis E, Evans MD, Mazepa M, Lim MY (2023). A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP Registry. Blood Adv, 8(3), 620-623. (Read full article)
7. Zafar A, Lim MY, Abou-Ismail MY (2023). Eculizumab in the management of drug-induced thrombotic microangiopathy: A scoping review of the literature. Thromb Res, 224, 73-79. (Read full article)
8. Kanack AJ, Jones CG, Singh B, Leger RR, Splinter NP, Heikal NM, Pruthi RK, Chen D, George G, Abou-Ismail MY, Wool GD, Gundabolu K, Padmanabhan A (2022). Off-the-shelf Cryopreserved Platelets for the Detection of HIT and VITT Antibodies. Blood, 140(25), 2722-2729. (Read full article)
9. Kanack A, Bayas A, George G, Abou-Ismail MY, Singh B, Kohlhagen M, Splinter N, Christ M, Naumann M, Moser KA, Smock KJ, Grazioli A, Wen R, Wang D, Murray DL, Padmanabhan A (2022). Monoclonal and Oligoclonal Anti-Platelet Factor 4 Antibodies Mediate VITT. Blood, 140(1), 73-77. (Read full article)
10. Abou-Ismail MY, Kanack A, Splinter N, Smock KJ, Moser K, Padmanabhan A (2022). Safety of BNT162b2 mRNA Vaccine Booster in the Setting of Ad26.COV2.S-associated VITT. Blood Adv, 6, 5327-5329. (Read full article)
11. Abou-Ismail MY, Fraser R, Allbee-Johnson M, Metheny L 3rd, Ravi G, Ahn KW, Bhatt NS, Lazarus HM, de Lima M, El Jurdy N, Hematti P, Beitinjaneh AM, Nishihori T, Badawy SM, Sharma A, Pasquini MC, Savani BN, Sorror ML, Stadtmauer EA, Chhabra S (2022). Does Recipient Body Mass Index Inform Donor Selection for Allogeneic Haematopoietic Cell Transplantation? Br J Haematol, 197, 326-338. (Read full article)
12. Kanack AJ, Singh B, George G, Gundabolu K, Koepsell SA, Abou-Ismail MY, Moser KA, Smock KJ, Green D, Major A, Chan CW, Wool GD, Reding M, Ashrani AA, Bayas A, Grill DE, Padmanabhan A (2022). Persistence of Ad26.COV2.S-associated Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT) and Specific Detection of VITT Antibodies. Am J Hematol, 97, 519-526. (Read full article)
13. Thomas VM, Abou-Ismail MY, Lim MY (2021). Off-label use of Emicizumab in Persons with Acquired Haemophilia A and von Willebrand Disease: A Scoping Review of the Literature. Haemophilia, 28(1), 4-17. (Read full article)
14. Abou-Ismail MY, Prchal JT, Deininger MW, Parker CJ, Lim MY (2021). Anticoagulation Management Post-transjugular Intrahepatic Portosystemic Shunt in Portal Hypertension Associated with Myeloproliferative Neoplasms. Blood Coagul Fibrinolysis, 32(8), 578-583. (Read full article)
15. Abou-Ismail MY, Ravi G, Fu P, Cao S, Vuyyala S, Caimi P, Kolk M, Ferrari N, Boughan K, Cooper B, Gallogly M, Otegbeye F, Tomlinson B, de Lima M, Metheny L (2020). History of Drug use in Allogeneic Hematopoietic Cell Transplant Recipients. Bone Marrow Transplant, 56(3), 581-585. (Read full article)
16. Abou-Ismail MY, Rodgers GM, Bray PF, Lim MY (2021). Acquired von Willebrand Syndrome in Monoclonal Gammopathy - A Scoping Review on Hemostatic Management. Res Pract Thromb Haemost, 5(2), 356-365. (Read full article)
17. Abou-Ismail MY, Arafah Y, Fu P, Cao S, Schmaier AH, Nayak L (2020). Outcomes of Immune Thrombotic Thrombocytopenic Purpura (iTTP) With Upfront Cyclophosphamide vs. Rituximab. Front Med (Lausanne), 7, 588526. (Read full article)
18. Abou-Ismail MY, Vuyyala S, Prunty J, Schmaier AH, Nayak L (2020). Short Term Efficacy of Recombinant Porcine Factor VIII in Patients with Factor VIII Inhibitors. Haemophilia, 26(4), 601-606. (Read full article)
19. Abou-Ismail MY, Ogunbayo GO, Secic M, Kouides PA (2017). Outgrowing the Laboratory Diagnosis of Type 1 von Willebrand Disease: A Two Decade Study. Am J Hematol, 93(2), 232-237. (Read full article)

Review

1. Al-Ghafry M, Abou-Ismail MY, Acharya SS (2024). Inherited Disorders of the Fibrinolytic Pathway: Pathogenic Phenotypes and Diagnostic Considerations of Extremely Rare Disorders. [Review]. Semin Thromb Hemost, 51(2), 227-235. (Read full article)
2. Lim MY, Abou-Ismail MY, Branch DW (2022). Differentiating and Managing Rare Thrombotic Microangiopathies during Pregnancy and Postpartum. [Review]. Obstet Gynecol, 141(1), 85-108. (Read full article)
3. Abou-Ismail MY, James PD, Flood VH, Connell NT (2022). Beyond the Guidelines: How we Approach Challenging Scenarios in the Diagnosis and Management of von Willebrand Disease. [Review]. J Thromb Haemost, 21(2), 204-214. (Read full article)
4. Abou-Ismail MY, Kapoor S, Citla Sridhar D, Nayak L, Ahuja S (2022). Thrombotic Microangiopathies: An Illustrated Review. [Review]. Res Pract Thromb Haemost, 6(3), e12708. (Read full article)
5. Abou-Ismail MY, Connell NT (2021). How to Manage Bleeding Disorders in Aging Patients Needing Surgery. [Review]. Hematology Am Soc Hematol Educ Program, 2021(1), 529-535. (Read full article)
6. Abou-Ismail MY, Diamond A, Kapoor S, Arafah Y, Nayak L (2020). The Hypercoagulable State in COVID-19: Incidence, Pathophysiology, and Management. [Review]. Thromb Res, 194, 101-115. (Read full article)
7. Abou-Ismail MY, Citla Sridhar D, Nayak L (2020). Estrogen and Thrombosis: A Bench to Bedside Review. [Review]. Thromb Res, 192, 40-51. (Read full article)
8. Citla Sridhar D, Abou-Ismail MY, Ahuja SP (2020). Central Venous Catheter-related Thrombosis in Children and Adults. [Review]. Thromb Res, 187, 103-112. (Read full article)

Editorial

1. Makris M, Abou-Ismail MY (2024). Navigating the inevitable: artificial intelligence and the future of scientific communication. Res Pract Thromb Haemost, 8(5), 102538. (Read full article)

Letter

1. Lim MY, Abou-Ismail MY (2021). Left Atrial Appendage Occlusion for Management of Atrial Fibrillation in Persons with Hemophilia. [Letter to the editor]. Thromb Res, 206, 9-13. (Read full article)
2. Abou-Ismail MY, Moser KA, Smock KJ, Lim MY (2021). Vaccine-induced Thrombotic Thrombocytopenia following Ad26.COV2.S Vaccine in a Man Presenting as Acute Venous Thromboembolism. [Letter to the editor]. Am J Hematol, 96(9), E346-E349. (Read full article)

Other

1. Le T, Bushan V (2013). Acknowledged contributor in Le T, Bushan V. First Aid for the USMLE Step 1. McGraw-Hill Medical.
2. Abou-Ismail MY (2013). Preimplantation Genetic Diagnosis: An Ethical Debate. Kira'at Volume III.
3. Abou-Ismail A, Abou-Ismail MY (2011). Addendum to Lab 14 Chapter Applying Biolab Concepts in Medicine. 1st year Premedical Program Biology Lab Manual - BIOG 103. Revised by Ogden CB, course director (Eds.).

News

• Suspected VITT Blood Clotting Case After Johnson & Johnson COVID-19 Vaccination
• Tres preguntas sobre las vacunas y los nuevos brotes Covid-19
• Coagulación de la sangre, Covid-19 y las vacunas
• Why Does the LGBTQIA+ Community Suffer from Poor Mental Health at Higher Rates?
• Blood Clotting, COVID-19 and Vaccines

Huntsman Cancer Institute News

• Blood Clots and Cancer: A Closer Look
• Cancer, Exercise, and Heat: Tips for Staying Cool